Home›Stock Screener›3B BlackBio DX

3B BlackBio DX Share Price Today | Stock Price & 3B BlackBio DX Share Screener

3BBLACKBIO Healthcare Service Provider
Live Share Price NSE
₹1624.70
▼ -22.10 (-1.34%)
2026-10-05 00:00:00
Live Share Price BSE
₹1630.30
▼ -24.50 (-1.48%)
2026-10-05 00:00:00

As of October 5, 2026, the live 3B BlackBio DX share price (NSE: 3BBLACKBIO) is ₹1,624.70 on NSE and ₹1,630.30 on BSE, down 1.34% from the previous close, with shares trading between ₹1,609.60 and ₹1,734.00 in today's trading session, and a 52-week range of ₹1,102.80–₹1,710.40. Check 3B BlackBio DX 52-week for the annual price range and momentum. Use the 3B BlackBio DX stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today 3B BlackBio DX opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Over the trailing twelve months the company reported revenue of ₹46 and net income of ₹10, with EBITDA of ₹19, an operating margin of 24.0% and a profit margin of 21.7%.

3B BlackBio DX Market Cap ₹1,394.43 Cr.
3BBLACKBIO P/E Ratio (TTM) 25.24
3B BlackBio DX P/B Ratio 4.38
EPS (TTM) ₹69.94
Dividend Yield 0.30%
Debt to Equity -
3BBLACKBIO 52 Week High ₹1710.40
3B BlackBio DX 52 Week Low ₹1102.80
Operating Margin 24.00%
Profit Margin 21.74%
3BBLACKBIO Revenue (TTM) ₹46.00
EBITDA ₹19.00
Net Income ₹10.00
Total Assets ₹378.00
Total Equity ₹324.00

3B BlackBio DX Share Price Chart

Track the current stock price of 3B BlackBio DX with an interactive chart. Analyse 3BBLACKBIO share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete 3B BlackBio DX stock quote in one place.

The quote of ₹1,624.70 sits between the 52-week low of ₹1,102.80 and the 52-week high of ₹1,710.40, and the latest session moved -1.34% from the previous close.

3B BlackBio DX Company Profile - Fundamental Screener

Screen 3B BlackBio DX company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for 3BBLACKBIO shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare Services sector and the Healthcare Service Provider industry, and it trades under ISIN INE994E01018.

Company Details

Classification

Sector Healthcare Services
Industry Healthcare Service Provider
Sub-Sector Healthcare Service Provider
Segment E

Identifiers and Leadership

ISIN INE994E01018

3B BlackBio DX Balance Sheet Screener

Screen 3BBLACKBIO balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹378, up from ₹296 in 2025.

Latest statistics put total assets at ₹378 and shareholder funds at ₹324.

Item 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017

Assets

Total Assets 378 296 248 214 192 194 45 36 30 26
Current Assets 193 132 123 114 82 118 39 32 26 22
Fixed Assets 28 7 7 8 7 5 4 4 4 3

Liabilities

Total Liabilities 0 0 0 0 0 0 0 0 0 0
Current Liabilities 10 6 5 4 3 2 2 3 3 4
Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0

Shareholders' Equity

Total Equity 324 271 226 196 172 148 34 23 19 11
Share Capital 9 9 9 9 8 8 8 6 6 6
Reserves & Surplus 316 260 215 185 146 125 25 16 12 5

3B BlackBio DX Income Statement Screener - Profit & Revenue Analysis

Screen 3B BlackBio DX income statement and profit fundamentals. Analyze 3BBLACKBIO quarterly results. 3B BlackBio DX reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For 2026-Mar, revenue was ₹46 and net profit was ₹10, equal to earnings per unit of ₹11.44, at an operating margin of 24%.

In that period expenses were ₹27, interest cost ₹0 and tax ₹5. The next period listed, 2026-Jun, shows revenue of ₹40 and net profit of ₹9.

Item 2026-Mar 2026-Jun 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar 2024-Jun 2024-Sept 2024-Dec 2023-Mar 2023-Jun 2023-Sept 2023-Dec 2022-Mar

Revenue and Expenses

Revenue 46 40 27 27 39 56 27 23 33 28 19 17 22 20 20
Expenses 27 25 15 10 19 29 13 9 13 10 11 8 11 9 13

Operating Costs and Margins

EBITDA 19 15 13 16 20 27 14 15 20 18 9 9 11 12 8
Operating Profit % 24.00% 25.00% 35.00% 53.00% 43.00% 43.00% 43.00% 56.00% 56.00% 59.00% 41.00% 45.00% 41.00% 50.00% 32.00%
Depreciation 4 1 0 0 1 0 0 0 0 0 0 0 0 0 0
Interest 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0

Profit and Earnings

Profit Before Tax 15 13 13 16 20 27 14 14 19 18 8 9 10 11 8
Tax 5 4 5 3 5 4 5 3 4 4 3 2 3 3 3
Net Profit 10 9 8 13 15 22 9 11 15 14 5 7 8 9 5
EPS 11.44 10.48 9.38 14.76 17.55 26.19 10.26 13.19 17.35 15.75 6.94 8.41 8.86 9.94 6.43

3B BlackBio DX Cash Flow Screener - Liquidity Fundamentals

Screen 3BBLACKBIO cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2025-March, operating activities generated ₹43, and net cash flow was an inflow of ₹7.

Over the same period, investing activities used ₹34 and financing activities used ₹3.

Item 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March 2016-March

Cash from Operations and Investing

Operating Activities 43 27 20 37 98 7 4 2 1 1
Investing Activities -34 -20 15 -28 -70 -1 -1 -1 0 0

Financing and Net Cash

Financing Activities -3 -4 -5 -15 -2 1 -1 0 0 -1
Net Cash Flow 7 3 30 -6 26 7 2 1 0 0

3B BlackBio DX Shareholding Pattern Screener

See 3B BlackBio DX shareholding pattern with promoter, FII, and DII holdings. Check 3B BlackBio DX promoter holding and ownership changes for 3BBLACKBIO on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Mar, promoters held 40.94%, foreign institutions 2.57%, domestic institutions 1.98% and the public 37.73%, spread across 10,616 shareholders.

The shareholder count was 10,616 in 2026-Mar, compared with 11,049 in 2026-Jun.

Item 2026-Mar 2026-Jun 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Feb 2024-Mar

Promoter Holding

Promoter Holding 40.94% 40.95% 41.28% 41.28% 41.28% 41.28% 41.29% 41.29%

Institutional Investors

FII Holding 2.57% 2.50% 2.49% 2.70% 2.64% 2.57% 2.97% 2.97%
DII Holding 1.98% 2.15% 1.60% 1.76% 1.82% 1.88% 1.89% 1.89%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 37.73% 37.05% 43.31% 43.17% 43.53% 38.09% 41.94% 41.94%
Other Holding 16.78% 17.35% 11.32% 11.09% 10.73% 16.19% 11.92% 11.92%
Shareholder Count 10,616 11,049 10,345 10,619 10,709 10,507 9,753 9,753

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by 3B BlackBio DX. 3B BlackBio DX dividend yield can be compared with peers and other stocks in the market.

The latest dividend recorded was ₹5.00 per unit for 2026-March, a yield of 0.30%, compared with ₹4.00 for 2025-March.

Dividends are listed for 10 periods, with the three most recent payouts at ₹5.00, ₹4.00 and ₹3.00 per unit.

Period Dividend Per Share Dividend Yield
2026-March ₹5.00 0.30%
2025-March ₹4.00 0.36%
2024-March ₹3.00 0.19%
2023-March ₹2.50 0.32%
2022-March ₹10.50 2.62%
2021-March ₹9.00 2.64%
2020-March ₹0.70 0.25%
2019-March ₹0.50 0.69%
2018-March ₹0.50 0.66%
2017-March ₹0.30 0.22%

3B BlackBio DX Stock Index Membership - Nifty & Sensex

See which indices include 3B BlackBio DX stock. Check 3BBLACKBIO index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

Complete Index List

3B BlackBio DX is not part of any tracked indices.
Only major market indices are tracked in our system.

3B BlackBio DX Market Events Screener - Corporate Actions

Get 3B BlackBio DX corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check 3B BlackBio DX stock events that may affect 3BBLACKBIO share price, along with derivatives, futures and options activity and sector gainers.

15 corporate actions are listed, the most recent entry being Annual General Meeting dated September 29, 2026, with a record date of September 29, 2026.

It is followed by Dividend dated September 22, 2026 and Quarterly Result Announcement dated August 13, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-09-29 2026-09-29 Annual General Meeting NA 6.63%
2026-09-22 2026-09-22 Dividend ₹ 5.00 /share 14.87%
2026-08-13 2026-08-13 Quarterly Result Announcement NA 1.02%
2026-05-29 2026-05-29 Quarterly Result Announcement NA -3.06%
2026-02-06 2026-02-06 Quarterly Result Announcement NA -2.84%
2025-11-13 2025-11-13 Quarterly Result Announcement NA 0.77%
2025-09-26 2025-09-26 Annual General Meeting NA -4.62%
2025-09-19 2025-09-19 Dividend ₹ 4.00 /share -29.01%
2025-08-14 2025-08-14 Quarterly Result Announcement NA 3.22%
2025-05-28 2025-05-28 Quarterly Result Announcement NA 15.56%
2025-02-13 2025-02-13 Quarterly Result Announcement NA -6.07%
2024-11-13 2024-11-13 Quarterly Result Announcement NA -3.07%
2024-09-24 2024-09-24 Annual General Meeting NA -8.48%
2024-09-17 2024-09-18 Dividend ₹ 3.00 /share 79.92%
2023-11-16 2023-11-16 Change Of Name NA 0.00%

3B BlackBio DX Competitors Screener - Peer Stocks Comparison

Screen 3BBLACKBIO competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare Services sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Dr. Lal Path Labs 33,088 61.65 2,864 12.11% 510 58.65
Vijaya Diagnostic Centre 14,648 78.49 835 19.34% 173 40.41
Metropolis Healthcare 11,481 55.01 1,671 24.15% 191 41.27
Thyrocare Technologies 8,628 48.36 846 20.48% 163 40.76
Nephrocare Health Services 6,412 76.48 1,023 32.93% 77 30.29
Krsnaa Diagnostics 1,814 18.46 816 9.90% 101 53.24
Suraksha Diagnostic 1,728 52.04 314 22.55% 31 48.03
3B BlackBio DX 1,394 25.24 142 27.17% 61 63.78
One Global Service Provider 1,069 13.95 499 237.48% 70 51.70
Health X Platform 881 -33.43 1,378 17.65% -1 34.79

3B BlackBio DX Company Announcements - News & Reports Screener

Screen 3BBLACKBIO latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated September 30, 2026.

The next most recent announcements are dated September 30, 2026 and September 29, 2026.

Date Update Actions
2026-09-30 Announcement under Regulation 30 (LODR)-Change in Management -
2026-09-30 Shareholder Meeting / Postal Ballot-Scrutinizers Report -
2026-09-29 Shareholder Meeting / Postal Ballot-Outcome of AGM -
2026-09-25 Closure of Trading Window -
2026-09-18 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-09-16 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome -
2026-09-11 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation -
2026-09-11 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome -
2026-09-08 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-09-07 Letter To Shareholders -
2026-09-07 Annual General Meeting To Be Held On 29Th September 2026 -
2026-09-07 Dividend Updates -
2026-09-07 Record Date And Date Of Book Closure For The Purpose Of Dividend And AGM -
2026-09-07 Reg. 34 (1) Annual Report. -
2026-09-07 Annual General Meeting To Be Held On 29Th September 2026 -
2026-09-05 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation -
2026-09-05 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-08-29 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome -
2026-08-25 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation -
2026-08-14 Announcement under Regulation 30 (LODR)-Newspaper Publication -

Frequently Asked Questions

How is the company valued right now?

The current quote is ₹1,624.70, within a 52-week range of ₹1,102.80 to ₹1,710.40. The P/E ratio is 25.24 and the P/B ratio is 4.38, with earnings per unit of ₹69.94. Market capitalisation stands at ₹1,394.43 Cr and the dividend yield is 0.30%. The company operates in the Healthcare Services sector, in the Healthcare Service Provider industry, so compare these ratios with its sector peers in the table above.

About This Data

Quotes are sourced from the NSE and the BSE. Key statistics were last updated on October 5, 2026. This page covers 10 balance sheet periods, 15 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.